Share on LinkedInShare on LinkedIn

ARTICLE · 27 NOVEMBER 2018

Patenting Regenerative Medicine In China

CCPIT Patent and Trademark Law Office
CCPIT Patent and Trademark Law Office
Contributor
CCPIT Patent and Trademark Law Office

CCPIT Patent and Trademark Law Office

CCPIT Patent and Trademark Law Office is the oldest and one of the largest full-service...

View firm profile
Explore more from CCPIT Patent and Trademark Law Office

Regenerative medicine, which aims at the process of replacing, engineering or regenerating human cells, tissues or organs, so as to restore or establish the normal function of a living organism ...

ChinaIntellectual Property

Regenerative medicine, which aims at the process of replacing, engineering or regenerating human cells, tissues or organs, so as to restore or establish the normal function of a living organism, is a prospective branch of medicine. Regenerative medicine is popular worldwide in the recent decade, and has broad applications. Many biological companies, research institutions and universities are conducting research in this field. In the same time, a large amount of patent applications in this field have been or are being filed. In this article, we will discuss typical issues in connection with patenting regenerative medicine in China, by referring to reexamination and invalidation decisions.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from